[Federal Register Volume 68, Number 209 (Wednesday, October 29, 2003)]
[Notices]
[Page 61700]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-27244]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated June 20, 2003, and published in the Federal 
Register on July 8, 2003, (68 FR 40686), Lilly Del Caribe, Inc., 
Chemical Plant, Kilometer 146.7, State Road 2, Mayaguez, Puerto Rico 
00680, made application by renewal to the Drug Enforcement 
Administration for registration as a bulk manufacturer of 
Dextropropoxyphene (9273), a basic class of controlled substance listed 
in Schedule II.
    The firm plans to bulk manufacture product for distribution to its 
customers.
    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, Section 832(a) and 
determined that the registration of Lilly Del Caribe, Inc. to 
manufacture the listed controlled substance is consistent with the 
public interest at this time. DEA has investigated Lilly Del Caribe, 
Inc. to ensure that the company's registration is consistent with the 
public interest. This investigation has included inspection and testing 
of the company's physical security systems, verification of the 
company's compliance with state and local laws, and a review of the 
company's background and history. Therefore, pursuant to 21 U.S.C. 823 
and 28 CFR 0.100 and 0.104, the Deputy Assistant Administrator, Office 
of Diversion Control, hereby orders that the application submitted by 
the above firm for registration as a bulk manufacturer of the basic 
class of controlled substance listed is granted.

Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 03-27244 Filed 10-28-03; 8:45 am]
BILLING CODE 4410-09-M